Search

Your search keyword '"Concialdi, Erika"' showing total 8 results
Start Over Author "Concialdi, Erika" Publication Year Range Last 3 years
8 results on '"Concialdi, Erika"'

2. Anaerobic bloodstream infections in Italy (ITANAEROBY): A 5-year retrospective nationwide survey

Author

Di Bella, Stefano, Antonello, Roberta Maria, Sanson, Gianfranco, Maraolo, Alberto Enrico, Giacobbe, Daniele Roberto, Sepulcri, Chiara, Ambretti, Simone, Aschbacher, Richard, Bartolini, Laura, Bernardo, Mariano, Bielli, Alessandra, Busetti, Marina, Carcione, Davide, Camarlinghi, Giulio, Carretto, Edoardo, Cassetti, Tiziana, Chilleri, Chiara, De Rosa, Francesco Giuseppe, Dodaro, Saveria, Gargiulo, Raffaele, Greco, Francesca, Knezevich, Anna, Intra, Jari, Lupia, Tommaso, Concialdi, Erika, Bianco, Gabriele, Luzzaro, Francesco, Mauri, Carola, Morroni, Gianluca, Mosca, Adriana, Pagani, Elisabetta, Parisio, Eva Maria, Ucciferri, Claudio, Vismara, Chiara, Luzzati, Roberto, and Principe, Luigi

Published
2022
Full Text
View/download PDF

3. A subanalysis of Clostridium perfringens bloodstream infections from a 5-year retrospective nationwide survey (ITANAEROBY)

Author

Maraolo, Alberto Enrico, Giacobbe, Daniele Roberto, Sepulcri, Chiara, Ambretti, Simone, Aschbacher, Richard, Bartolini, Laura, Bernardo, Mariano, Bielli, Alessandra, Busetti, Marina, Carcione, Davide, Camarlinghi, Giulio, Carretto, Edoardo, Cassetti, Tiziana, Chilleri, Chiara, De Rosa, Francesco Giuseppe, Dodaro, Saveria, Gargiulo, Raffaele, Greco, Francesca, Knezevich, Anna, Intra, Jari, Lupia, Tommaso, Concialdi, Erika, Bianco, Gabriele, Luzzaro, Francesco, Mauri, Carola, Morroni, Gianluca, Mosca, Adriana, Pagani, Elisabetta, Parisio, Eva Maria, Ucciferri, Claudio, Vismara, Chiara, Geremia, Nicholas, Sanson, Gianfranco, Principe, Luigi, Antonello, Roberta Maria, Zerbato, Verena, Luzzati, Roberto, and Di Bella, Stefano

Published
2024
Full Text
View/download PDF

4. Legionella pneumophila Infections during a 7-Year Retrospective Analysis (2016–2022): Epidemiological, Clinical Features and Outcomes in Patients with Legionnaires’ Disease

Author

Lupia, Tommaso, primary, Corcione, Silvia, additional, Shbaklo, Nour, additional, Rizzello, Barbara, additional, De Benedetto, Ilaria, additional, Concialdi, Erika, additional, Navazio, Anna Sara, additional, Penna, Maurizio, additional, Brusa, Maria Teresa, additional, and De Rosa, Francesco Giuseppe, additional

Published
2023
Full Text
View/download PDF

5. Prognostic evaluation of

Author

De Benedetto, Ilaria, Lupia, Tommaso, Shbaklo, Nour, Bianchi, Alessandro, Concialdi, Erika, Penna, Maurizio, Corcione, Silvia, and De Rosa, Francesco Giuseppe

Subjects
Original Articles
Abstract

BACKGROUND: Since the emergence of the pandemic of SARS-CoV-2, a high reported incidence of VAP in COVID-19 sustained by carbapenem resistant Acinetobacter baumannii (CRAB) has been observed, but data are scarce to date. MATERIALS AND METHODS: We retrospectively collected COVID-19 patients who developed CRAB-VAP - defined according to Center for Diseases Control (CDC) 2020 criteria and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) or Infectious Diseases Society of America (IDSA) guidelines - to describe characteristics and outcome. RESULTS: Among 21 patients with CRAB-VAP in COVID-19, median age was 66 years (IQR 41–80). Median time of VAP-onset was 7 days (IQR 0–28 days) from ICU - admission and 76.2% had septic shock. Treatment regimens were all colistin-based, in 28% (n=6) including ampicillin/sulbactam and rifampicin. In three cases, cefiderocol was started as rescue. Survival rate at 28-days was 35% (n=7). CONCLUSION: Non-fermenting Gram-negative bacteria are an emerging aetiology of VAP in COVID-19 patients. This underscores the urgent need for proper microbiological identification to address therapies and infection control protocols.

Published
2022

6. A Regional Observational Study on COVID-19-Associated Pulmonary Aspergillosis (CAPA) within Intensive Care Unit: Trying to Break the Mold

Author

Lupia, Tommaso, primary, Montrucchio, Giorgia, additional, Gaviraghi, Alberto, additional, Musso, Gaia, additional, Puppo, Mattia, additional, Bolla, Cesare, additional, Shbaklo, Nour, additional, Rizzello, Barbara, additional, Della Selva, Andrea, additional, Concialdi, Erika, additional, Rumbolo, Francesca, additional, Barbui, Anna Maria, additional, Brazzi, Luca, additional, De Rosa, Francesco Giuseppe, additional, and Corcione, Silvia, additional

Published
2022
Full Text
View/download PDF

8. Prognostic evaluation of Acinetobacter baumannii ventilator-associated pneumonia in COVID-19.

Author

De Benedetto I, Lupia T, Shbaklo N, Bianchi A, Concialdi E, Penna M, Corcione S, and De Rosa FG

Abstract

Background: Since the emergence of the pandemic of SARS-CoV-2, a high reported incidence of VAP in COVID-19 sustained by carbapenem resistant Acinetobacter baumannii (CRAB) has been observed, but data are scarce to date., Materials and Methods: We retrospectively collected COVID-19 patients who developed CRAB-VAP - defined according to Center for Diseases Control (CDC) 2020 criteria and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) or Infectious Diseases Society of America (IDSA) guidelines - to describe characteristics and outcome., Results: Among 21 patients with CRAB-VAP in COVID-19, median age was 66 years (IQR 41-80). Median time of VAP-onset was 7 days (IQR 0-28 days) from ICU - admission and 76.2% had septic shock. Treatment regimens were all colistin-based, in 28% (n=6) including ampicillin/sulbactam and rifampicin. In three cases, cefiderocol was started as rescue. Survival rate at 28-days was 35% (n=7)., Conclusion: Non-fermenting Gram-negative bacteria are an emerging aetiology of VAP in COVID-19 patients. This underscores the urgent need for proper microbiological identification to address therapies and infection control protocols., Competing Interests: Conflict of interest None to declare. Funding information No competing interest to disclose.

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results